Ling S, Ogungbenro K, Darwich A, Ariff A, Nair N, Bluett J
Pharmaceutics. 2024; 16(6).
PMID: 38931826
PMC: 11206727.
DOI: 10.3390/pharmaceutics16060702.
Jyssum I, Gehin J, Sexton J, Kristianslund E, Hu Y, Warren D
Rheumatology (Oxford). 2023; 63(6):1746-1755.
PMID: 37773994
PMC: 11147536.
DOI: 10.1093/rheumatology/kead525.
Krieckaert C, Hernandez-Breijo B, Gehin J, Le Meledo G, Balsa A, Jani M
RMD Open. 2022; 8(2).
PMID: 35980738
PMC: 9171282.
DOI: 10.1136/rmdopen-2022-002216.
Hiltunen J, Parmanne P, Sokka T, Lamberg T, Isomaki P, Kaipiainen-Seppanen O
Rheumatol Int. 2021; 42(6):1015-1025.
PMID: 34357455
PMC: 9124652.
DOI: 10.1007/s00296-021-04955-8.
Bensalem A, Mulleman D, Thibault G, Azzopardi N, Goupille P, Paintaud G
Br J Clin Pharmacol. 2019; 85(12):2747-2758.
PMID: 31454097
PMC: 6955400.
DOI: 10.1111/bcp.14102.
Golimumab Dried Blood Spot Analysis (GOUDA): a Prospective Trial Showing Excellent Correlation with Venepuncture Samples and More Detailed Pharmacokinetic Information.
Detrez I, Schops G, Lefrere J, Tops S, Van Assche G, Vermeire S
AAPS J. 2018; 21(1):10.
PMID: 30564993
DOI: 10.1208/s12248-018-0282-x.
Adalimumab concentration-based tapering strategy: as good as the recommended dosage.
Mulleman D, Balsa A
Ann Rheum Dis. 2018; 77(4):473-475.
PMID: 29306871
PMC: 5890625.
DOI: 10.1136/annrheumdis-2017-212376.
Practical recommendations for the use of therapeutic drug monitoring of biopharmaceuticals in inflammatory diseases.
Dreesen E, Bossuyt P, Mulleman D, Gils A, Pascual-Salcedo D
Clin Pharmacol. 2017; 9:101-111.
PMID: 29042821
PMC: 5633318.
DOI: 10.2147/CPAA.S138414.
Clinical Pharmacokinetics and Pharmacodynamics of Monoclonal Antibodies Approved to Treat Rheumatoid Arthritis.
Ternant D, Bejan-Angoulvant T, Passot C, Mulleman D, Paintaud G
Clin Pharmacokinet. 2015; 54(11):1107-23.
PMID: 26123705
DOI: 10.1007/s40262-015-0296-9.
Pharmacokinetics and concentration-effect relationship of adalimumab in rheumatoid arthritis.
Ternant D, Ducourau E, Fuzibet P, Vignault C, Watier H, Lequerre T
Br J Clin Pharmacol. 2014; 79(2):286-97.
PMID: 25223394
PMC: 4309634.
DOI: 10.1111/bcp.12509.
Judicious use of biologicals in juvenile idiopathic arthritis.
Zhao Y, Wallace C
Curr Rheumatol Rep. 2014; 16(11):454.
PMID: 25218736
DOI: 10.1007/s11926-014-0454-3.
